19996 Federal Register / Vol. 76, No. 69 / Monday, April 11, 2011 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Funding 

Opportunity Announcement (FOA), 

Initial Review 

The meeting announced below 

concerns ‘‘Longitudinal Study of a 

Population-based Cohort of People with 

Lupus,’’ FOA DP11–004, initial review. 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time and Date: 

11 a.m.–5 p.m., May 04, 2011 (Closed). 

Place: Teleconference 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c) (4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters To Be Discussed: The meeting will 

include the initial review, discussion, and 

evaluation of applications received in 

response to ‘‘Longitudinal Study of a 

Population-based Cohort of People with 

Lupus,’’ FOA DP11–004, initial review. 

Contact Person for More Information: 

Brenda Colley Gilbert, Ph.D., M.P.H., 

Director, Extramural Research Program 

Office, National Center for Chronic Disease 

Prevention and Health Promotion, CDC, 1600 

Clifton Road, NE., Mailstop K92, Atlanta, 

Georgia 30333, Telephone: (770) 488–6295. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: April 4, 2011. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2011–8508 Filed 4–8–11; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2011–N–0012] 

Cooperative Agreement With the 

University of Mississippi’s National 

Center for Natural Products Research 

(U01) To Develop and Disseminate 

Botanical Natural Product Research 

With an Emphasis on Public Safety 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing the 

availability of grant funds for the 

support of a cooperative agreement with 

the University of Mississippi’s National 

Center for Natural Products Research 

(UM–NCNPR). The goal of the 

cooperative agreement is to promote the 

efficient development and 

dissemination of natural products 

research and science and the programs 

developed under the agreement will 

complement the diverse activities of 

both the public and private sectors. 

DATES: Important dates are as follows: 

1. The application due date is May 1, 

2011. 

2. The anticipated start date is June 1, 

2011. 

3. The opening date is April 11, 2011. 

4. The expiration date is May 2, 2011. 

For Further Information and 

Additional Requirements Contact: 

Scientific/Programmatic Contacts: 

Jeanne I. Rader, Center for Food Safety 

and Applied Nutrition (HFS–715), 

5100 Paint Branch Pkwy., College 

Park, MD 20740, 301–436–1786, FAX: 

301–436–2622, e-mail: 

Jeanne.Rader@fda.hhs.gov; or 

Steven L. Robbs, Center for Food Safety 

and Applied Nutrition (HFS–006), 

5100 Paint Branch Pkwy., College 

Park, MD 20740, 301–436–2146, FAX: 

301–436–2618, e-mail: 

Steven.Robbs@fda.hhs.gov; or 

LaQuia S. Geathers, Center for Food 

Safety and Applied Nutrition (HFS– 

680), 5100 Paint Branch Pkwy., 

College Park, MD 20740, 301–436– 

2821, FAX: 301–436–2629, e-mail: 

LaQuia.Geathers@fda.hhs.gov. 

Grants Management Contact: 

Vieda Hubbard, Office of Acquisitions 

and Grants Services (HFA–500), 5630 

Fishers Lane, Rm. 2141, Rockville, 

MD 20857, 301–827–7177, FAX: 301– 

827–7101, e-mail: 

Vieda.Hubbard@fda.hhs.gov. 

For more information on this funding 

opportunity announcement (FOA) and 

to obtain detailed requirements, please 

refer to the full FOA located at http:// 

grants2.nih.gov/grants/guide and http:// 

www.fda.gov/Food/NewsEvents/ 

default.htm. 

SUPPLEMENTARY INFORMATION: 

I. Funding Opportunity Description 

RFA–FD–11–004 

Catalog of Federal Domestic 

Assistance Number(s): 93.103 https:// 

www.cfda.gov. 

A. Background 

The primary focus of the UM– 

NCNPR/FDA cooperative agreement is 

to develop and disseminate botanical 

natural product research with an 

emphasis on public safety according to 

the needs of FDA. The cooperative 

research, education, and outreach 

programs developed by UM–NCNPR 

will address scientific issues related to 

the safety of botanical dietary 

supplements (BDS) and botanical 

ingredients and will complement the 

diverse activities of both the public and 

private sectors. 

B. Research Objectives 

This cooperative agreement will 

define the research projects, workshops, 

conferences, partnerships with 

academia, industry, non-governmental 

organizations, and international 

organizations and other activities on 

which the FDA and UM–NCNPR will 

collaborate. Specifically, this 

cooperative agreement will provide 

continued support so that UM–NCNPR 

can: 

• Assist in the identification and 

development of a list of BDS and 

botanical ingredients, based on safety 

concerns, trends, and knowledge of 

botanicals being marketed in the United 

States, to prioritize for further research. 

• Acquire, validate, and characterize 

authenticated reference materials, 

including raw and processed plant 

materials and purified natural products 

of relevance to FDA, for evaluation of 

their safety. 

• Exchange technical and scientific 

information, analytical methods, and 

reference material with FDA scientists 

and other stakeholders. 

• Collaborate with FDA scientists in 

research areas of mutual interest. 

• Coordinate scientific workshops 

and conferences on BDS-related topics 

of public health relevance to address 

high priority science and research 

needs. 

C. Eligibility Information 

NCNPR has the unique capability to 

bring together diverse scientific 


srobinson on DSKHWCL6B1PROD with NOTICES